Inhibition of choriodecidual cytokine production and inflammatory gene expression by selective I‐κB kinase (IKK) inhibitors
Authors:
Open Access
- 3 May 2010
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 160 (7) , 1808-1822
Abstract
BACKGROUND AND PURPOSE: Inflammation of the extraplacental membranes plays a key role in the pathogenesis of preterm labour. The aim of this study was to screen a number of commercially available small molecule nuclear factor‐kappa B inhibitors to identify candidates suitable for clinical evaluation as anti‐inflammatory agents for the prevention of preterm birth. EXPERIMENTAL APPROACH: Nine inhibitors were evaluated across a range of concentrations for their ability to inhibit lipopolysaccharide (LPS)‐stimulated cytokine production in primary term choriodecidual cells in culture without affecting cell viability. Expression of 112 inflammation‐ and apoptosis‐related genes was evaluated using boutique oligonucleotide arrays. KEY RESULTS: Two IKKβ inhibitors were found to be highly effective and non‐toxic inhibitors of choriodecidual cytokine production: parthenolide and [5‐(p‐fluorophenyl)‐2‐ureido] thiophene‐3‐carboxamide (TPCA‐1). Both compounds also inhibited LPS‐stimulated nuclear translocation of p65/RelA. Expression of 38 genes on the arrays (34%) was significantly ( P < 0.05) inhibited by TPCA‐1 or parthenolide. Of the 14 genes significantly stimulated by LPS, all were inhibited by TPCA‐1 and 12 were inhibited by parthenolide. Overall, gene expression was more robustly inhibited by TPCA‐1 than parthenolide; however, expression of two genes was only inhibited by parthenolide. Neither compound significantly altered the expression profile of anti‐apoptosis genes on the arrays. CONCLUSIONS AND IMPLICATIONS: These studies provide evidence that pharmacological inhibition of IKKβ activity holds promise as a potential strategy for the prevention and/or treatment of inflammation‐driven preterm birth. TPCA‐1 appeared the most promising compound among those tested in this study. Different inhibitors may have subtly different effect profiles despite having similar modes of action.Keywords
This publication has 59 references indexed in Scilit:
- Inhibition by a Selective IκB Kinase-2 Inhibitor of Interleukin-1–Induced Collagen Degradation by Corneal Fibroblasts in Three-Dimensional CultureInvestigative Ophthalmology & Visual Science, 2008
- Attenuation of Lipopolysaccharide-Induced Inflammatory Response and Phospholipids Metabolism at the Feto-Maternal Interface by N-Acetyl CysteinePediatric Research, 2008
- Analysis of the IKKβ/NF‐κB signaling pathway during embryonic angiogenesisDevelopmental Dynamics, 2008
- Microbial Prevalence, Diversity and Abundance in Amniotic Fluid During Preterm Labor: A Molecular and Culture-Based InvestigationPLOS ONE, 2008
- IKKα is a critical coregulator of a Smad4-independent TGFβ-Smad2/3 signaling pathway that controls keratinocyte differentiationProceedings of the National Academy of Sciences, 2008
- Pretreatment With Toll-like Receptor 4 Antagonist Inhibits Lipopolysaccharide-Induced Preterm Uterine Contractility, Cytokines, and Prostaglandins in Rhesus MonkeysReproductive Sciences, 2008
- NF-κB Is a Negative Regulator of IL-1β Secretion as Revealed by Genetic and Pharmacological Inhibition of IKKβCell, 2007
- Antenatal infection/inflammation and fetal tissue injuryBest Practice & Research Clinical Obstetrics & Gynaecology, 2007
- The Effects of a Ceramide Analogue, N-acetylsphingosine, on Basal and Tumor Necrosis Factor-α-Stimulated Production of Prostaglandins and Cytokines in Gestational TissuesProstaglandins & Other Lipid Mediators, 1998
- Inhibition of the Expression of Inducible Cyclooxygenase and Proinflammatory Cytokines by Sesquiterpene Lactones in Macrophages Correlates with the Inhibition of MAP KinasesBiochemical and Biophysical Research Communications, 1996